- Home
- STRO vs TORO Comparison
STRO vs TORO Comparison
Compare STRO & TORO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | STRO | TORO |
|---|---|---|
| Founded | 2003 | 2022 |
| Country | United States | Cyprus |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.0M | 84.0M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | STRO | TORO |
|---|---|---|
| Price | $16.60 | $3.77 |
| Analyst Decision | Hold | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $18.88 | N/A |
| AVG Volume (30 Days) | ★ 131.7K | 120.9K |
| Earning Date | 03-12-2026 | 12-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $105,646,000.00 | $20,203,079.00 |
| Revenue This Year | $63.08 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.23 | $1.70 |
| 52 Week High | $21.25 | $6.15 |
Technical Indicators
Market Signals| Indicator | STRO | TORO |
|---|---|---|
| Relative Strength Index (RSI) | 74.44 | 26.07 |
| Support Level | $14.08 | $3.61 |
| Resistance Level | $17.33 | $4.58 |
| Average True Range (ATR) | 1.47 | 0.34 |
| MACD | 0.17 | -0.25 |
| Stochastic Oscillator | 89.28 | 7.09 |
Price Performance
Historical ComparisonAbout STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About TORO Toro Corp.
Toro Corp acquires, owns, charters, and operates oceangoing tanker vessels and provides seaborne transportation services for crude oil and refined petroleum products. It operates in three reportable segments: the Aframax tanker, the LPG carrier segment, and the Handysize tanker. The company generates maximum revenue from the Aframax tanker segment.